Antibodies against type I interferon: detection and association with severe clinical outcome in COVID‐19 patients-Reference-Cited by-同舟云学术

Antibodies against type I interferon: detection and association with severe clinical outcome in COVID‐19 patients

Published:2021-01 Issue:8 Volume:10 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin Transl Immunol

Author:

Goncalves David¹^ORCID,Mezidi Mehdi²³^ORCID,Bastard Paul⁴⁵⁶^ORCID,Perret Magali¹⁷^ORCID,Saker Kahina⁸^ORCID,Fabien Nicole¹^ORCID,Pescarmona Rémi¹⁷^ORCID,Lombard Christine¹^ORCID,Walzer Thierry⁷^ORCID,Casanova Jean‐Laurent⁴⁵⁶^ORCID,Belot Alexandre⁷⁹¹⁰^ORCID,Richard Jean‐Christophe²³^ORCID,Trouillet‐Assant Sophie⁷⁸^ORCID

Affiliation:

1. Immunology Department Lyon Sud HospitalHospices Civils de Lyon Pierre‐Bénite France

2. CREATIS CNRS UMR5220 Inserm U1044 INSA Lyon University Lyon France

3. Intensive Care Unit Hospices Civils de Lyon Lyon France

4. Laboratory of Human Genetics of Infectious Diseases Necker Branch INSERM U1163 Necker Hospital for Sick Children Paris France

5. Imagine Institute University of Paris Paris France

6. St. Giles Laboratory of Human Genetics of Infectious Diseases Rockefeller Branch The Rockefeller University New York NY USA

7. International Center of Research in Infectiology INSERM U1111 CNRS UMR 5308 ENS UCBL Lyon University Lyon France

8. Infective Agents Institute Hospices Civils de Lyon Lyon France

9. National Referee Centre for Rheumatic and AutoImmune and Systemic diseases in childrEn (RAISE) Lyon France

10. Pediatric Nephrology, Rheumatology, Dermatology Unit Hospices Civils de Lyon Lyon France

Funder

Hospices Civils de Lyon

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1327

Reference10 articles.

1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

2. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

3. Type I IFN immunoprofiling in COVID-19 patients

4. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

5. Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The ASC inflammasome adapter governs SAA-derived protein aggregation in inflammatory amyloidosis;EMBO Molecular Medicine;2024-07-30

2. Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies;Journal of Experimental Medicine;2024-07-17

3. [Review] The Landscape of Interferons in Health and Disease;2024-07-15

4. Exploring the protective association between COVID-19 infection and laryngeal cancer: insights from a Mendelian randomization study;Frontiers in Immunology;2024-06-10

5. Salivary autoantibodies to type I IFNs: Mirror plasma levels, predispose to severe COVID-19, and enhance feasibility for clinical screening;Heart & Lung;2024-06